Accumulation of 24S-hydroxycholesterol in neuronal SK-N-BE cells treated with hexacosanoic acid (C26:0): Argument in favor of 24S-hydroxycholesterol as a potential biomarker of neurolipotoxicity

Revue Neurologique

Volumn 171, Issue 2, 2015, Pages 125-129

  Zarrouk, A ^a,b   Hammami, M ^b   Moreau, T ^c   Lizard, G ^a  

^a INSERM   (France)

^b UNIVERSITY OF MONASTIR   (Tunisia)

^c DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

24S hydroxycholesterol; Hexacosanoic acid (C26:0); Lipotoxicity; Neuronal stress

Indexed keywords

24 HYDROXYCHOLESTEROL; BIOLOGICAL MARKER; CHOLESTEROL DERIVATIVE; HEXACOSANOIC ACID; LONG CHAIN FATTY ACID; UNCLASSIFIED DRUG; 24-HYDROXYCHOLESTEROL; CHOLESTEROL; FATTY ACID; LIPID;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOTHESIS; LEUKODYSTROPHY; LIPOTOXICITY; NERVE CELL; NEUROLIPOTOXICITY; NEUROTOXICITY; ANIMAL; BRAIN; CELL LINE; DRUG EFFECTS; METABOLISM; NEUROTOXICITY SYNDROMES;

ALZHEIMER DISEASE; ANIMALS; BIOMARKERS; BRAIN; CELL LINE; CHOLESTEROL; FATTY ACIDS; HUMANS; HYDROXYCHOLESTEROLS; LIPIDS; NEURONS; NEUROTOXICITY SYNDROMES;

EID: 84923096201     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2014.10.016     Document Type: Review

References (23)

1. Kou J, Kovacs GG, Höftberger R, Kulik W, Brodde A, Forss-Petter S, et al. Peroxisomal alterations in Alzheimer's disease. Acta Neuropathol 2011; 122: 271-83.
2. Lizard G, Hammami M, Zarrouk A. Biomarqueur de la maladie d'Alzheimer; 2013 [patent number: 13.58513].
3. Zarrouk A. Implication de l'acide docosanoïque (C22: 0) et des acides gras à très longue chaîne (acide tétracosanoïque (C24: 0), acide hexacosanoïque (C26: 0)) dans la maladie d'Alzheimer : aspects biologiques et cliniques.[doctoral dissertation] universitéde Bourgogne; 2013.
4. Savary S, Trompier D, Andréoletti P, Le Borgne F, Demarquoy J, Lizard G. Fatty acids-induced lipotoxicity and inflammation. Curr Drug Metab 2012; 13: 1358-70.
5. Eichler FS, Ren JQ, Cossoy M, Rietsch AM, Nagpal S, Moser AB, et al. Is microglial apoptosis an early pathogenic change in cerebral X-linked adrenoleukodystrophy? Ann Neurol 2008; 63: 729-42.
6. Leoni V, Caccia C. 24S-hydroxycholesterol in plasma: a marker of cholesterol turnover in neurodegenerative diseases. Biochimie 2013; 95: 595-612.
7. Aubourg P. X-linked adrenoleukodystrophy. Ann Endocrinol (Paris) 2007; 68: 403-11.
8. Kemp S, Wanders RJ. X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment. Mol Genet Metab 2007; 90: 268-76.
9. Baarine M, Andréoletti P, Athias A, Nury T, Zarrouk A, Ragot K, et al. Evidence of oxidative stress in very long chain fatty acid-treated oligodendrocytes and potentialization of ROS production using RNA interference-directed knockdown of ABCD1 and ACOX1 peroxisomal proteins. Neuroscience 2012; 213: 1-18.
10. Zarrouk A, Vejux A, Nury T, El Hajj HI, Haddad M, Cherkaoui-Malki M, et al. Induction of mitochondrial changes associated with oxidative stress on very long chain fatty acids (C22: 0, C24: 0, or C26: 0)-treated human neuronal cells (SK-NB-E). Oxid Med Cell Longev 2012; 2012: 623257.
11. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957; 226: 497-509.
12. Fourgeux C, Martine L, Pasquis B, Maire MA, Acar N, Creuzot-Garcher C, et al. Steady-state levels of retinal 24S-hydroxycholesterol are maintained by glial cells intervention after elevation of intraocular pressure in the rat. Acta Ophthalmol 2012; 90: e560-7.
13. Leoni V, Long JD, Mills JA, Di Donato S, Paulsen JS, PREDICT-HD study group. Plasma 24S-hydroxycholesterol correlation with markers of Huntington disease progression. Neurobiol Dis 2013; 55: 37-43.
14. Ragot K, Mackrill JJ, Zarrouk A, Nury T, Aires V, Jacquin A, et al. Absence of correlation between oxysterol accumulation in lipid raft microdomains, calcium increase, and apoptosis induction on 158N murine oligodendrocytes. Biochem Pharmacol 2013; 86: 67-79.
15. Björkhem I. Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. J Intern Med 2006; 260: 493-508.
16. Valianpour F, Selhorst JJ, van Lint LE, van Gennip AH, Wanders RJ, Kemp S. Analysis of very long-chain fatty acids using 1387 electrospray ionization mass spectrometry. Mol Genet Metab 2003; 79: 189-96.
17. Okabe A, Urano Y, Itoh S, Suda N, Kotani R, Nishimura Y, et al. Adaptive responses induced by 24S-hydroxycholesterol through liver X receptor pathway reduce 7-ketocholesterol-caused neuronal cell death. Redox Biol 2013; 2: 28-35.
18. Gamba P, Leonarduzzi G, Tamagno E, Guglielmotto M, Testa G, Sottero B, et al. Interaction between 24-hydroxycholesterol, oxidative stress, and amyloid-b in amplifying neuronal damage in Alzheimer's disease: three partners in crime. Aging Cell 2011; 10: 403-17.
19. Alexandrov P, Cui JG, Zhao Y, Lukiw WJ. 24S-hydroxycholesterol induces inflammatory gene expression in primary human neural cells. Neuroreport 2005; 16: 909-13.
20. Lund EG, Guileyardo JM, Russell DW. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc Natl Acad Sci U S A 1999; 96: 7238-43.
21. Leoni V, Caccia C. Potential diagnostic applications of side chain oxysterols analysis in plasma and cerebrospinal fluid. Biochem Pharmacol 2013; 86: 26-36.
22. van de Kraats C, Killestein J, Popescu V, Rijkers E, Vrenken H, Lütjohann D, et al. Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis. Mult Scler 2014; 20: 412-7.
23. Leoni V, Caccia C. Oxysterols as biomarkers in neurodegenerative diseases. Chem Phys Lipids 2011; 164: 515-24.